Vector Development
Researchers' findings advance Vector Development research
Published in Vaccine Weekly, January 25th, 2006
Study 1: Researchers review HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy in a recent issue of Current Gene Therapy.
"Herpes simplex virus type 1(HSV-1) is a major human pathogen whose lifestyle is based on a long-term dual interaction with the infected host characterized by the existence of lytic and latent infections. Although in most cell types infection with HSV-1 will induce toxic effects ending in the death of the infected cells, the very deep knowledge we possess on the genetics and molecular biology of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-01-25)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Mice immunized with chloroplast-derived anthrax antigen survive lethal challenge - Malaria Vaccine
Epitopes delivered by polymeric linear peptides protect against malaria - Meningitis Vaccine
N. meningitidis conjugate vaccine induces protective antibodies - Trichomoniasis Vaccine
Proteinase plus adjuvant prevent Trichomonas genital infections - Tularemia Vaccine
Attenuated Francisella tularensis mutant is an effective live vaccine - Adenovirus Vaccine
Review focused on inactivating antiviral responses during adenovirus infection - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
